Anne Mattingly, MD
Surgical Oncology · Danville, INNPI 1174842595
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,347 of the $2,743 with a category attached, or 85.6%. It is spread thinly across 38 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations.
Across 113 payments — averaging $24.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$564
- Merck$338
- Novartis$314
- Johnson & Johnson$196
- AstraZeneca$193
- Exelixis Inc.$81
- plus $1K from 32 others
What the payments were for
- Travel & lodging$39614%
- Food & beverage$2,34786%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 6 | $564 |
| Merck | 17 | $338 |
| Novartis | 20 | $314 |
| Johnson & Johnson(2 entities) | 7 | $196 |
| AstraZeneca | 9 | $193 |
| Exelixis Inc. | 4 | $81 |
| Daiichi Sankyo Inc. | 3 | $77 |
| Tempus AI, Inc | 3 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| Genentech USA, Inc. | 4 | $60 |
| Pharmacosmos Therapeutics Inc. | 3 | $57 |
| AbbVie | 2 | $54 |
| Blueprint Medicines Corporation | 2 | $50 |
| Lilly USA, LLC | 3 | $50 |
| Coherus Oncology, Inc. | 2 | $43 |
| Incyte Corporation | 2 | $38 |
| Bayer | 2 | $34 |
| Tersera Therapeutics LLC | 1 | $33 |
| Corcept Therapeutics | 1 | $29 |
| Adaptive Biotechnologies Corporation | 1 | $29 |
| Pfizer | 1 | $28 |
| Janssen Scientific Affairs, LLC | 1 | $27 |
| Eisai Inc. | 1 | $24 |
| Spectrum Pharmaceuticals Inc. | 1 | $24 |
| Elucent Medical | 1 | $23 |
| Genmab U.S., Inc. | 1 | $22 |
| Gilead | 1 | $21 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $21 |
| Deciphera Pharmaceuticals Inc. | 1 | $19 |
| Legend Biotech USA Inc. | 1 | $19 |
| Puma Biotechnology, Inc. | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Acrotech Biopharma Inc. | 1 | $17 |
| Rigel Pharmaceuticals, Inc. | 1 | $17 |
| Beone Medicines USA, Inc. | 1 | $16 |
| Shield Therapeutics Inc | 1 | $15 |
| Sobi, Inc | 1 | $15 |
| Veracyte, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few surgical oncology providers in Indianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $51 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Danville
- Monet BowlingDanville$2K
- Sharmila Roy-ChowdhuryGoshen$10K
- Jon CardinalIndianapolis$6K
- Tara SpiveyAnderson$4K
- Ambria MotenFort Wayne$4K
- Timothy GoeddeIndianapolis$3K
- Nathaniel LeeIndianapolis$2K
- Joshua KaysIndianapolis$717
- Stephanie SchickIndianapolis$606
- Gopal MenonGoshen$555
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.